Blood Brain-Derived Neurotrophic Factor (BDNF) and Major Depression: Do We Have a Translational Perspective?
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Major depressive disorder (MDD) affects millions of people worldwide and is a leading cause of disability. Several theories have been proposed to explain its pathological mechanisms, and the “neurotrophin hypothesis of depression” involves one of the most relevant pathways. Brain-derived neurotrophic factor (BDNF) is an important neurotrophin, and it has been extensively investigated in both experimental models and clinical studies of MDD. Robust empirical findings have indicated an association between increased BDNF gene expression and peripheral concentration with improved neuronal plasticity and neurogenesis. Additionally, several studies have indicated the blunt expression of BDNF in carriers of the Val66Met gene polymorphism and lower blood BDNF (serum or plasma) levels in depressed individuals. Clinical trials have yielded mixed results with different treatment options, peripheral blood BDNF measurement techniques, and time of observation. Previous meta-analyses of MDD treatment have indicated that antidepressants and electroconvulsive therapy showed higher levels of blood BDNF after treatment but not with physical exercise, psychotherapy, or direct current stimulation. Moreover, the rapid-acting antidepressant ketamine has presented an early increase in blood BDNF concentration. Although evidence has pointed to increased levels of BDNF after antidepressant therapy, several factors, such as heterogeneous results, low sample size, publication bias, and different BDNF measurements (serum or plasma), pose a challenge in the interpretation of the relation between peripheral blood BDNF and MDD. These potential gaps in the literature have not been properly addressed in previous narrative reviews. In this review, current evidence regarding BDNF function, genetics and epigenetics, expression, and results from clinical trials is summarized, putting the literature into a translational perspective on MDD. In general, blood BDNF cannot be recommended for use as a biomarker in clinical practice. Moreover, future studies should expand the evidence with larger samples, use the serum or serum: whole blood concentration of BDNF as a more accurate measure of peripheral BDNF, and compare its change upon different treatment modalities of MDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · cited 3×
“Interestingly, compared with Val carriers, healthy Met allele carriers showed worse episodic memory function, reduced hippocampal physiologic performance in functional magnetic resonance, and reduced prefrontal and hippocampal gray matter volume in previous studies (Egan et al., 2003; Pezawas et al., 2004; Szeszko et…”
BackgroundA Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · cited 1×
“Several pathophysiological systems are implicated in MDD, such as the immune system, autonomic nervous system, and hypothalamic–pituitary–adrenal axis, as well as primary brain systems, including the monoaminergic brain circuitries and the neurotrophic support pathway (Krishnan and Nestler, 2008).”
BackgroundNeurotrophins and their receptors: A convergence point for many signalling pathways
Chao, M. V. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1078 · Cited by 2,298 · cited 5×
“BDNF is part of a family of structurally related peptides, named neurotrophins, which are able to interact with two classes of receptors expressed on cell membrane surfaces, namely, tropomyosin receptor kinase (Trk) A–C, which binds to diverse neurotrophins, and the p75 neurotrophin receptor (p75NTR) (Chao, 2003).”
BackgroundInfluentialA molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Neurotrophin regulation of neural circuit development and function
Park, H., & Poo, M.-M. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3379 · Cited by 2,060 · cited 1×
“The neurotrophin hypothesis of depression proposes that most of the antidepressant effect comes from the increase in BDNF expression and concentration, which improves neuronal plasticity (Park and Poo, 2013).”
BackgroundNMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · cited 2×
“Interestingly, the BDNF levels increased after an average time of 4 h after a low-dose infusion of ketamine, completely different from the evidence with other antidepressants, which require a more prolonged time (Autry et al., 2011; Kavalali and Monteggia, 2012; Haile et al., 2014).”
BackgroundNeurotrophins as synaptic modulators
Poo, M.-M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35049004 · Cited by 1,775 · cited 4×
“…these patients, the postmortem cortex levels of BDNF were correlated with circulating serum BDNF levels, and the protein levels were associated with cognitive decline evaluated by the Mini Mental State Examination score (Poo, 2001; Michalski and Fahnestock, 2003; L. Tapia-Arancibia et al., 2008).”
BackgroundMethodInfluentialEpidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
Hasin, D. S., Sarvet, A. L., Meyers, J. L., Saha, T. D., Ruan, W. J., Stohl, M., & Grant, B. F. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4602 · Cited by 1,737 · cited 2×
“Of the total episodes, 12% are hospitalized at some point (Hasin et al., 2018).”
BackgroundBrain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Why sex matters for neuroscience
Cahill, L. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1909 · Cited by 1,540
Exercise as a treatment for depression: a meta-analysis adjusting for publication bias
Schuch, F. B., Vancampfort, D., Richards, J., Rosenbaum, S., Ward, P. B., & Stubbs, B. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.02.023 · Cited by 1,529 · cited 1×
“Physical exercise is an evidence-based treatment strategy to improve depression with a moderate effect size (Schuch et al., 2016).”
BackgroundTransport of brain-derived neurotrophic factor across the blood–brain barrier
Pan, W., Banks, W. A., Fasold, M. B., Bluth, J., & Kastin, A. J. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00141-5 · Cited by 1,354
Decreased serum brain-derived neurotrophic factor levels in major depressed patients
Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G., & Aubry, J.-M. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00005-7 · Cited by 1,232 · cited 1×
“Taken together, this evidence stimulated seminal clinical studies showing low serum levels of BDNF in depressed individuals with a direct proportional relation between BDNF concentration and depressive symptomatology (Karege et al., 2002), as well as an increase in serum BDNF levels during antidepressant treatment (Sh…”
ResultSen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232
New insights into BDNF function in depression and anxiety
Martinowich, K., Manji, H., & Lu, B. (2007) · Nature Neuroscience · doi:10.1038/nn1971 · Cited by 1,221 · cited 2×
“Most previous integrative reviews on BDNF in MDD date more than 10 years ago (Groves, 2007; Martinowich et al., 2007).”
BackgroundExercise treatment for depression
Dunn, A. L., Trivedi, M. H., Kampert, J. B., Clark, C. G., & Chambliss, H. O. (2005) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2004.09.003 · Cited by 1,208
Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00181-1 · Cited by 1,151 · cited 1×
“, 2002), as well as an increase in serum BDNF levels during antidepressant treatment (Shimizu et al., 2003).”
BackgroundMechanisms of ketamine action as an antidepressant
Zanos, P., & Gould, T. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.255 · Cited by 1,127 · cited 1×
“An increase in synaptic BDNF levels in γ-aminobutyric acid interneurons appears to be a major mechanism of action of ketamine (Zanos and Gould, 2018).”
BackgroundBeneficial effects of physical exercise on neuroplasticity and cognition
Hötting, K., & Röder, B. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.005 · Cited by 991 · cited 1×
“Animal studies have shown that physical exercise is associated with increased expression of BDNF in the hippocampus, which may improve memory performance and reduce depressive symptoms by promoting neurogenesis and neuronal differentiation (Hötting and Röder, 2013).”
BackgroundBrunoni, A. R., Lopes, M., & Fregni, F. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009309 · Cited by 972
A meta-analytic review of the effects of exercise on brain-derived neurotrophic factor
Szuhany, K. L., Bugatti, M., & Otto, M. W. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.10.003 · Cited by 909
Pezawas, L., Verchinski, B. A., Mattay, V. S., Callicott, J. H., Kolachana, B. S., Straub, R. E., Egan, M. F., Meyer-Lindenberg, A., & Weinberger, D. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2680-04.2004 · Cited by 890
Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00349.2003 · Cited by 800
Interaction between BDNF and Serotonin: Role in Mood Disorders
Martinowich, K., & Lu, B. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301571 · Cited by 793 · cited 1×
“in brain areas implicated in depression (Martinowich and Lu, 2008).”
Brain-derived Neurotrophic Factor Is Stored in Human Platelets and Released by Agonist Stimulation
Fujimura, H., Chen, R., Nakamura, T., Nakahashi, T., Kambayashi, J.-I., Sun, B., Altar, C., & Tandon, N. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613072 · Cited by 777 · cited 2×
“Additionally, during the process of preparing blood samples to measure serum BDNF, coagulation and centrifugation processes result in platelet release of BDNF, increasing its level (Fujimura et al., 2002).”
BackgroundBlood BDNF Concentrations Reflect Brain-Tissue BDNF Levels across Species
Klein, A. B., Williamson, R., Santini, M. A., Clemmensen, C., Ettrup, A., Rios, M., Knudsen, G. M., & Aznar, S. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000738 · Cited by 726 · cited 1×
“Central and peripheral levels of BDNF are highly correlated (Klein et al., 2011).”
BackgroundMolendijk, M. L., Spinhoven, P., Polak, M., Bus, B. A. A., Penninx, B. W. J. H., & Elzinga, B. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.105 · Cited by 702 · cited 3×
“…at least five important metaanalyses regarding the serum BDNF response to antidepressants (Brunoni et al., 2008; Sen et al., 2008; Bocchio-Chiavetto et al., 2010; Molendijk et al., 2014; Zhou et al., 2017) have also been published aiming to identify peripheral biomarkers for antidepressant therapy.”
BackgroundInfluentialPruunsild, P., Kazantseva, A., Aid, T., Palm, K., & Timmusk, T. (2007) · Genomics · doi:10.1016/j.ygeno.2007.05.004 · Cited by 699 · cited 2×
“The human BDNF gene is located on chromosome 11p13 and consists of 11 exons and 9 functional promoters that are tissue-specific and brain region–specific (Pruunsild et al., 2007).”
BackgroundWilkinson, S. T., Ballard, E. D., Bloch, M. H., Mathew, S. J., Murrough, J. W., Feder, A., Sos, P., Wang, G., Zarate, C. A., & Sanacora, G. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17040472 · Cited by 696
Hock, C., Heese, K., Hulette, C., Rosenberg, C., & Otten, U. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.846 · Cited by 523 · cited 1×
“Indeed, the gene and protein expression of BDNF is severely reduced in the hippocampus and temporal and frontal cortex regions in Alzheimer disease brain (Phillips et al., 1991; Hock et al., 2000; Patapoutian and Reichardt, 2001; Fahnestock et al., 2002; Michalski and Fahnestock, 2003).”
BackgroundPolyakova, M., Stuke, K., Schuemberg, K., Mueller, K., Schoenknecht, P., & Schroeter, M. L. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.044 · Cited by 488
Verhagen, M., van der Meij, A., van Deurzen, P. A. M., Janzing, J. G. E., Arias-Vásquez, A., Buitelaar, J. K., & Franke, B. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.109 · Cited by 470 · cited 4×
“Val66Met and Sex Environment and Ethnicity Interestingly, in a large meta-analysis, the Met allele significantly increased the risk of depression in men but not in women (Verhagen et al., 2010).”
BackgroundResultInfluentialTaliaz, D., Stall, N., Dar, D. E., & Zangen, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.67 · Cited by 454
The Role of BDNF on Neural Plasticity in Depression
Yang, T., Nie, Z., Shu, H., Kuang, Y., Chen, X., Cheng, J., Yu, S., & Liu, H. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00082 · Cited by 435
Serum and plasma BDNF levels in major depression: A replication study and meta-analyses
Bocchio-Chiavetto, L., Bagnardi, V., Zanardini, R., Molteni, R., Gabriela Nielsen, M., Placentino, A., Giovannini, C., Rillosi, L., Ventriglia, M., Riva, M. A., et al. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622971003611319 · Cited by 435
Effect of treatment on serum brain–derived neurotrophic factor levels in depressed patients
Gonul, A. S., Akdeniz, F., Taneli, F., Donat, O., Eker, Ç., & Vahip, S. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0578-6 · Cited by 375 · cited 1×
“Two previous studies showed that selective serotonin receptor inhibitor (SSRI) and serotonin and norepinephrine receptor inhibitor (SNRI) treatment for 2 months increased serum BDNF (Gonul et al., 2005; Yoshimura et al., 2007).”
BackgroundBernard, R., Kerman, I. A., Thompson, R. C., Jones, E. G., Bunney, W. E., Barchas, J. D., Schatzberg, A. F., Myers, R. M., Akil, H., & Watson, S. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.44 · Cited by 372
BDNF release is required for the behavioral actions of ketamine
Lepack, A. E., Fuchikami, M., Dwyer, J. M., Banasr, M., & Duman, R. S. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu033 · Cited by 368
Dinoff, A., Herrmann, N., Swardfager, W., & Lanctôt, K. L. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13603 · Cited by 323
Duman, R. S., Deyama, S., & Fogaça, M. V. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14630 · Cited by 321
Low plasma BDNF is associated with suicidal behavior in major depression
Kim, Y.-K., Lee, H.-P., Won, S.-D., Park, E.-Y., Lee, H.-Y., Lee, B.-H., Lee, S.-W., Yoon, D., Han, C., Kim, D.-J., et al. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.024 · Cited by 300 · cited 1×
“Generally, patients with suicide attempts and a high risk of suicide showed lower levels of serum or plasma BDNF (Dawood et al., 2007; Deveci et al., 2007; Kim et al., 2007).”
BackgroundDeterminants of serum brain-derived neurotrophic factor.
Bus, B. A. A., Molendijk, M. L., Penninx, B. J. W. H., Buitelaar, J. K., Kenis, G., Prickaerts, J., Elzinga, B. M., & Voshaar, R. C. O. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.07.013 · Cited by 279
Self-citationSynaptic Mechanisms Underlying Rapid Antidepressant Action of Ketamine
Kavalali, E. T., & Monteggia, L. M. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12040531 · Cited by 258
Haile, C. N., Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Foulkes, A., Iqbal, S., Mahoney, J. J., De La Garza, R., Charney, D. S., et al. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001119 · Cited by 253
Gideons, E. S., Kavalali, E. T., & Monteggia, L. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323920111 · Cited by 232 · cited 1×
“ketamine is reinforced by the lack of the same benefit for other NMDA-R antagonists (memantine), a blunt in antidepressant action of ketamine in deletion mutant mice, and a blocked action after infusion of anti-BDNF in the medial prefrontal cortex (Autry et al., 2011; Gideons et al., 2014; Lepack et al., 2014).”
BackgroundLaje, G., Lally, N., Mathews, D., Brutsche, N., Chemerinski, A., Akula, N., Kelmendi, B., Simen, A., McMahon, F. J., Sanacora, G., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.031 · Cited by 213 · cited 1×
“Additionally, the presence of the BDNF Val66Met polymorphism may blunt the antidepressant and antisuicidal effects of ketamine (Laje et al., 2012).”
BackgroundAlboni, S., van Dijk, R. M., Poggini, S., Milior, G., Perrotta, M., Drenth, T., Brunello, N., Wolfer, D. P., Limatola, C., Amrein, I., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2015.142 · Cited by 207
Neuronal network plasticity and recovery from depression
Castrén, E. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1 · Cited by 190 · cited 2×
“…presumes that antidepressant treatment does not directly improve mood, but rather creates a favorable condition through increased brain plasticity to the action of the environment, which is fundamental to ensure recovery and is amplified by antidepressant action (Branchi, 2011; Castrén, 2013).”
BackgroundZhou, C., Zhong, J., Zou, B., Fang, L., Chen, J., Deng, X., Zhang, L., Zhao, X., Qu, Z., Lei, Y., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0172270 · Cited by 187
Brain-derived Neurotrophic Factor in Megakaryocytes
Chacón-Fernández, P., Säuberli, K., Colzani, M., Moreau, T., Ghevaert, C., & Barde, Y.-A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.720029 · Cited by 186 · cited 1×
“In humans, peripherally detectable BDNF is mostly related to its presence in megakaryocytes and platelets, but these cells do not have nuclei to synthetize BDNF (Chacón-Fernández et al., 2016).”
BackgroundLaske, C., Banschbach, S., Stransky, E., Bosch, S., Straten, G., Machann, J., Fritsche, A., Hipp, A., Niess, A., & Eschweiler, G. W. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709991234 · Cited by 171 · cited 1×
“Most studies involving older adults with depression observed lower plasma or serum levels of BDNF (Diniz et al., 2010; Laske et al., 2010; Shi et al., 2010; Chu et al., 2012).”
BackgroundStress and Disease: Is Being Female a Predisposing Factor?
Becker, J. B., Monteggia, L. M., Perrot-Sinal, T. S., Romeo, R. D., Taylor, J. R., Yehuda, R., & Bale, T. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3565-07.2007 · Cited by 158
Branchi, I. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.08.011 · Cited by 156
BDNF promoter methylation and genetic variation in late-life depression
Januar, V, Ancelin, M.-L., Ritchie, K., Saffery, R., & Ryan, J. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.114 · Cited by 139 · cited 1×
“Interestingly, late-life depression was also associated with elevated BDNF methylation of specific CpG sites within BDNF promoters I and IV (Januar et al., 2015).”
BackgroundRocha, R. B., Dondossola, E. R., Grande, A. J., Colonetti, T., Ceretta, L. B., Passos, I. C., Quevedo, J., & da Rosa, M. I. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.08.004 · Cited by 119 · cited 3×
“Two recent meta-analyses included studies with MDD patients treated with ECT, in which pretreatment and posttreatment BDNFs were evaluated (Rocha et al., 2016; Luan et al., 2020).”
BackgroundMethodBDNF genotype moderates the relation between physical activity and depressive symptoms.
Mata, J., Thompson, R. J., & Gotlib, I. H. (2010) · Health Psychology · doi:10.1037/a0017261 · Cited by 119
Dell׳Osso, B., D׳Addario, C., Carlotta Palazzo, M., Benatti, B., Camuri, G., Galimberti, D., Fenoglio, C., Scarpini, E., Di Francesco, A., Maccarrone, M., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.020 · Cited by 112 · cited 1×
“, 2014) and depression in patients characterized by bipolar II disorders (Dell’Osso et al., 2014).”
BackgroundLongitudinal multi-level biomarker analysis of BDNF in major depression and bipolar disorder
Schröter, K., Brum, M., Brunkhorst-Kanaan, N., Tole, F., Ziegler, C., Domschke, K., Reif, A., & Kittel-Schneider, S. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-01007-y · Cited by 68 · cited 3×
“DNA methylation of the BDNF gene has been widely investigated, showing increased BDNF methylation levels in patients with MDD (Schröter et al., 2020).”
BackgroundPei, Y., Smith, A. K., Wang, Y., Pan, Y., Yang, J., Chen, Q., Pan, W., Bao, F., Zhao, L., Tie, C., et al. (2012) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32062 · Cited by 67 · cited 1×
“However, the presence of the BDNF Val66Met polymorphism was associated with geriatric depression in a previous meta-analysis of studies of late-life depression with low level of heterogeneity and publication bias (Pei et al., 2012).”
BackgroundDinoff, A., Herrmann, N., Swardfager, W., Gallagher, D., & Lanctôt, K. L. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.08.021 · Cited by 50 · cited 1×
“Six studies were evaluated in a recent meta-analysis with conflicting results regarding the effect of physical exercise on resting concentrations of BDNF among MDD patients, and the peripheral BDNF concentrations were not increased after an exercise intervention (Dinoff et al., 2018).”
Result
Cited by
Zhang, K., Wang, F., Zhai, M., He, M., Hu, Y., Feng, L., Li, Y., Yang, J., & Wu, C. (2023) · Theranostics · doi:10.7150/thno.81067 · Cited by 217
Cavaleri, D., Moretti, F., Bartoccetti, A., Mauro, S., Crocamo, C., Carrà, G., & Bartoli, F. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105159 · Cited by 146
Liu, X., Li, P., Ma, X., Zhang, J., Sun, X., Luo, X., & Zhang, Y. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.07.041 · Cited by 34
Rafało-Ulińska, A., Brański, P., & Pałucha-Poniewiera, A. (2022) · Pharmaceuticals · doi:10.3390/ph15020125 · Cited by 29
Positive Allosteric Modulators of Trk Receptors for the Treatment of Alzheimer’s Disease
Forsell, P., Parrado Fernández, C., Nilsson, B., Sandin, J., Nordvall, G., & Segerdahl, M. (2024) · Pharmaceuticals · doi:10.3390/ph17080997 · Cited by 14
Metadata
- Authors
- Arosio, B., Guerini, F. R., Voshaar, R. C. O., & Aprahamian, I.
- Venue
- Frontiers in Behavioral Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2021-02-12
- Volume
- 15
- Pages
- 626906-626906
- ISSN
- 1662-5153 (ISSN-L)
- OpenAlex
- W3131777201
- Cited by
- 145
- References
- 65
- FWCI
- 12.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.